ADIM
CNM icon

Alpha DNA Investment Management’s Core & Main CNM Stock Holding History

Alpha DNA Investment Management’s Portfolio CNM Stock Details CNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25,121
Closed -$571K – 158
2022
Q3 		$571K Sell
25,121
-19,340
-43% -$452K 0.47% 90
2022
Q2 		$991K Buy
+44,461
New +$1.03M 0.85% 59

Other funds holding CNM

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Alpha DNA Investment Management's CNM Position: Q4 2022 in Review

Alpha DNA Investment Management sold out of Core & Main (CNM) in Q4 2022, closing a stake of 25,121 shares — an estimated $571K sold.

Alpha DNA Investment Management first reported a position in CNM in Q2 2022 and held it in 2 quarters. The position peaked at $991K in Q2 2022. 165 funds tracked by Wall St. Rank hold CNM as of Q4 2022.

  • Alpha DNA Investment Management reported no remaining Core & Main position as of Q4 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 25,121 Core & Main shares in Q4 2022, an estimated $571K.
  • Alpha DNA Investment Management first reported a position in Core & Main in Q2 2022 and held it in 2 quarters.
  • Alpha DNA Investment Management's Core & Main position peaked at $991K in Q2 2022.
  • 165 funds tracked by Wall St. Rank held Core & Main as of Q4 2022.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.